These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28517961)

  • 1. Overcoming chemoresistance in cancer stem cells with the help of microRNAs in colorectal cancer.
    Fesler A; Guo S; Liu H; Wu N; Ju J
    Epigenomics; 2017 Jun; 9(6):793-796. PubMed ID: 28517961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
    Fanale D; Barraco N; Listì A; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer.
    Liu X; Fu Q; Du Y; Yang Y; Cho WC
    Curr Cancer Drug Targets; 2016; 16(9):738-754. PubMed ID: 26577538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
    Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J
    Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs are important regulators of drug resistance in colorectal cancer.
    Zhang Y; Wang J
    Biol Chem; 2017 Jul; 398(8):929-938. PubMed ID: 28095367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance.
    Zhong C; Wang G; Guo M; Zhu N; Chen X; Yan Y; Li N; Yu W
    Cancer Control; 2024; 31():10732748241274196. PubMed ID: 39215442
    [No Abstract]   [Full Text] [Related]  

  • 7. Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1
    Chen B; Zhang D; Kuai J; Cheng M; Fang X; Li G
    Tumour Biol; 2017 Jun; 39(6):1010428317715155. PubMed ID: 28639895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs and colorectal cancer chemoresistance: New solution for old problem.
    Vaghari-Tabari M; Majidinia M; Moein S; Qujeq D; Asemi Z; Alemi F; Mohamadzadeh R; Targhazeh N; Safa A; Yousefi B
    Life Sci; 2020 Oct; 259():118255. PubMed ID: 32818543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment.
    Yang HZ; Ma Y; Zhou Y; Xu LM; Chen XJ; Ding WB; Zou HB
    Cancer Lett; 2015 May; 361(1):128-36. PubMed ID: 25749420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-141 inhibits tumor growth and minimizes therapy resistance in colorectal cancer.
    Ye J; Wang Z; Zhao J; Chen W; Wu D; Wu P; Huang J
    Mol Med Rep; 2017 Mar; 15(3):1037-1042. PubMed ID: 28112364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
    Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
    Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
    Zhai H; Fesler A; Ba Y; Wu S; Ju J
    Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells.
    Sun J; Xu K; Qiu Y; Gao H; Xu J; Tang Q; Yin P
    Oncol Rep; 2017 Sep; 38(3):1420-1430. PubMed ID: 28731184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
    To KK; Leung WW; Ng SS
    Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of miR-27a sensitizes colorectal cancer stem cells to TRAIL by promoting the formation of Apaf-1-caspase-9 complex.
    Zhang R; Xu J; Zhao J; Bai J
    Oncotarget; 2017 Jul; 8(28):45213-45223. PubMed ID: 28423356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
    Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K
    Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil.
    Pouya FD; Gazouli M; Rasmi Y; Lampropoulou DI; Nemati M
    Mol Biol Rep; 2022 Jun; 49(6):5165-5178. PubMed ID: 35212928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
    Zhang Y; Talmon G; Wang J
    Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
    Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
    Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.